Ann: Interim data in Phase 2 study of SNT-5505 in myelofibrosis, page-29

  1. 101 Posts.
    lightbulb Created with Sketch. 61
    Advanced publication of the interim results in Haematologica journal. Abstract now in full paper form! Haematologica uses an international peer review system and only ~20% make publication.
    https://www.researchgate.net/publication/390876450_A_phase_I_IIa_trial_of_PXS-5505_a_novel_pan-lysyl_oxidase_inhibitor_in_advanced_myelofibrosis/fulltext/68018a72bfbe974b23ab1da9/A-phase-I-IIa-trial
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
5.7¢
Change
-0.010(14.9%)
Mkt cap ! $92.60M
Open High Low Value Volume
6.7¢ 6.7¢ 5.5¢ $569.7K 9.664M

Buyers (Bids)

No. Vol. Price($)
1 5000 5.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.7¢ 468564 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.